Collagen is widely present in human tissues and plays a crucial role in maintaining tissue structure and function. Type XVII collagen is a key component that connects the cytoskeleton and basement membrane, helping to maintain skin integrity. Recent studies have shown that Type XVII collagen is not only associated with skin diseases but also acts as a key factor in regulating various stem cells, which are related to aging symptoms such as hair loss and gray hair. During skin wound healing, Type XVII collagen plays an important role by influencing the migration, proliferation, and differentiation of stem cells. With the development of synthetic biology technology, recombinant Type XVII collagen can be obtained through synthetic biotechnology. As a new type of therapeutic protein and anti-aging ingredient, it has great application potential in skin repair and anti-aging fields.
On October 12, Frost & Sullivan, in collaboration with Jiangsu Chuangjian Medical Technology Co., Ltd., released the ‘White Paper on Recombinant Type XVII Collagen’ in Chongqing.
